This website uses cookies to deliver to you the best experience possible on SITC CONNECT. By continuing to use this site, you are providing to us your consent to ensure you receive such an experience.
View our privacy policy to learn more.
OK
Search Options
Join SITC
Renew
Make a Gift
Skip to main content (Press Enter).
Sign in
Skip auxiliary navigation (Press Enter).
Subscribe
Skip main navigation (Press Enter).
Toggle navigation
Educational & Scientific Programs
ConnectED
Cancer Immunotherapy Winter School
SITC Immuno-Oncology Drug Development Summit
Webinars and Online Education
Advances in Cancer Immunotherapy (ACI) Webinars
AI in IO: SITC-NCI Computational IO Series
Definitions, End Points, and Clinical Trial Designs for Bladder Cancer
Expanding Access to Cellular and Bispecific Therapies
2024 Glyco-Immunology Webinar Series
Immunomodulation of ADCs Virtual Summit
Intralesional Virtual Summit
Increasing Access to IO: A Global Webinar Series
Immune Exclusion Virtual Summit
Immunoprevention Virtual Summit
SITC Clinical Practice Guidelines Online Education
Targets for Cancer IO: A Deep Dive Series
Call for Proposals
Annual Meeting & Pre-Conference Programs
39th Annual Meeting & Pre-Conference Programs
Past and Future Annual Meetings & Pre-Conference Programs
Collaborative Education Programs
Patient and Survivor Education and Resources
Workshops
Tumor Immune Microenvironment: A Holistic Approach
Surfaceome Virtual Workshop
Bispecific T cell Engagers Virtual Workshop
Cytokines in Cancer Immunotherapy Virtual Workshop
Advances in Cancer Immunotherapy
SITC Biotech Initiative
Spring Scientific
2025 Spring Scientific
Past and Future Spring Scientific Programs
Calendar of Events
Professional Development & Training
Certificate in Cancer Immunotherapy
Professional Interest Communities
Fellowships
Women in Cancer Immunotherapy Network (WIN)
Women in Cancer Immunotherapy Network 2024
Women in SITC Community
Early Career Scientist (ECS) Committee
Clinical Trials Training and Resources
SITC Clinical Immuno-Oncology Network (SCION) Workshop
Maximizing the Value of Phase III Trials in Immuno-Oncology
ICI-related Adverse Events Terminology Definitions
Definitions, End Points, and Clinical Trial Designs for Bladder Cancer
Intratumoral Immunotherapy Clinical Trial (IICT) Design
NCI Immunotherapy Fellowship
SITC Sparkathon
Sparkathon 2025
Support Sparkathon
Other Resources
Calendar of Events
Path to SITC Leadership
Publications & Guidelines
Journal for ImmunoTherapy of Cancer
About JITC
Become a Reviewer
For Authors
From the Editors
JITC Collections and Special Issues
SITC Immunotherapy Books
SITC's Guide to Managing Immunotherapy Toxicity Textbook
Cancer Immunotherapy Principles and Practice Textbook, 2nd Ed.
SITC Scientific Publications News
SITC Clinical Practice Guidelines
Clinical Practice Guidelines
Clinical Practice Guidelines Online Education
Clinical Practice Guidelines Mobile App
SITC Cancer Immunotherapy Guideline News
Patient Resource Guides
Access & Advocacy
SITC Immuno-oncology Drug Development Summit
Policy
Advocacy News
Global Immunotherapy Access
Crisis in Clinical Research
Expanding Access to Cellular and Bispecific Therapies
Patient & Survivor Education & Resources
Membership
2024 SITC Election
Connect-a-Colleague
Volunteer
Volunteer with SITC
Academy of Immuno-Oncology
About the Academy
Corporate Membership
Benefits, Categories & Application
Members Only
SITC Member Directory
Support SITC
The Forward Fund
Moving the Field Forward
Making a Difference
Named Funds and Awards
Early Career Scientist Awards
Richard V. Smalley Memorial Award and Lectureship
Steven A. Rosenberg Scholars Award
Technology Awards
Martin "Mac" Cheever Travel Award Fund
Sparkathon
The CheckPoints: SITC’s House Band
Ways to Make a Gift
Donate
Stocks and Securities
Estate and Planned Gifts
Corporate Support and Giving Opportunities
Corporate Giving Opportunities
Corporate Membership
Educational Grants
Sponsorship & Advertising
SITC Merchandise
Honor and Memorial Gifts
Make a Gift in Honor of a Loved One
Make a Gift in Memory of a Loved One
Our Donors and Supporters
2022 SITC Supporters
Forward
Fund Donors
About SITC
Strategic Plan
Awards and Recognition
Career Connections
SITC’s DEI Strategy
Elevating a Rich Oncology Community: SITC’s DEI Strategic Plan
Virtual Roundtable on Diversity in Clinical Trial Enrollment
Partnerships
Contact SITC
SITC Biotech Initiative
Board of Directors
Committees, Task Forces and Professional Interest Communities
Mission & Vision
Media Room
SITC Press Releases
Scientific Meeting Highlights from SITC
Immune Monitor Archive
JITC Digest Archive
Cancer Immunotherapy Month
SITC Policies
The Connect Community
Create Account
My Profile
My Communities
My Libraries
The Sentinel - SITC Blog
SITC CPG Webinar – Case Studies in Immunotherapy for the Treatment of Multiple Myeloma
When:
Jun 16, 2021 from 17:00 to 18:00 (ET)
On Wednesday, June 16, 2021 from 5 – 6 pm ET, join leading experts from the SITC Cancer Immunotherapy Guidelines Multiple Myeloma Expert Panel for the "SITC Clinical Practice Guideline Webinar – Case Studies in Immunotherapy for the Treatment of Multiple Myeloma." This high-level webinar is designed so that attendees will be able to execute the use of immunotherapy with increased confidence, plan management strategies for difficult cases, and identify and discuss areas of controversy in the immunotherapy field.
Webinar Faculty:
Moderator: Madhav Dhodapkar, MD —
Winship Cancer Institute, Emory University
(Expert Panel Chair)
Amrita Krishnan, MD —
Judy and Bernard Briskin Multiple Myeloma Center for Clinical Research, City of Hope Comprehensive Cancer Center
(Expert Panel Member)
Ravi Vij, MD, MBA —
Washington University School of Medicine in St. Louis
(Expert Panel Member)
REGISTER NOW
This webinar is supported, in part, by independent medical education grant funding from Amgen and Merck & Co., Inc. (as of 6/7/21)
#Myeloma
#ClinicalPracticeGuideline
Download to Your Calendar
Contact
connectED@sitcancer.org
Membership Links
Join
Renew
Member Directory
My Profile
Get Involved
Email Sign-up
Volunteer
Support SITC
Contact Us
© 2024 Society for Immunotherapy of Cancer (SITC). All rights reserved.
Powered by Higher Logic